Sign in

CIK 0001280776 · Non-accelerated filer<br>Smaller reporting company

IMMUNIC, INC.

Sign in to watch
Ticker
IMUX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
562358443
Phone
(332) 255-9818
Business address
1200 AVENUE OF THE AMERICAS, SUITE 200, NEW YORK, United States, 10036
Former names
VITAL THERAPIES INC
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 8-K Event Material agreement
  5. EFFECT Other Notice of Effectiveness
  6. 424B3 Offering Prospectus
  7. CORRESP Other Correspondence Between Filers and SEC Staff
  8. UPLOAD Other SEC-generated Letter
  9. 4 Open-market buy Director bought 82,000 shares at an average $1.25 ($102,642)
  10. S-3 Offering Registration Statement
  11. SC 13G Stake Amended Statement of Ownership
  12. 4 Open-market buy Director bought 18,000 shares at $1.39 ($25,020)
  13. SC 13G Stake Amended Statement of Ownership
  14. SC 13G Stake Amended Statement of Ownership
  15. 4 Open-market buy President and CEO bought 8,000 shares at $1.35 ($10,799)
  16. 8-K Event Other events
  17. 4 Open-market buy Chief Financial Officer bought 5,000 shares at $1.50 ($7,475)
  18. 10-Q Report Quarterly Report
  19. 8-K Event Results of operations · Other events
  20. SC 13G Stake Amended Statement of Ownership

Page 14 of 42 · 832 filings